Global Insulin Delivery Devices Market Insights
Insulin is a hormone that regulates blood-sugar levels in diabetic patients. There are several ways to administer insulin to a patient using various devices such as syringes, pens, pumps, jet sprays, etc. The global insulin delivery devices market is expected to foray ahead at a healthy CAGR of 7% over a forecast period of 2020-2030. Analyzing through the market lens, it is expected to climb up in terms of revenue, to US$ 14 billion by the end of FY 2020.
The COVID-19 pandemic has also affected the insulin delivery devices market in an important way. This is one of the few markets that has seen a rise in scale due to the pandemic. The situation has extensively increased demand for protective products, including insulin delivery devices such as insulin pens, pumps, syringes, etc. The pandemic has proven to be an important factor in the expansion of the insulin delivery devices market size in 2020.
Insulin Delivery Devices Market Product Type Insights
Insulin delivery can be carried out in a number of ways, of which, prominent types are insulin pens, insulin syringes, and insulin pumps. Insulin pens are easier to inject insulin as compared to syringes. Considering the market, insulin pens are the leading products occupying a larger market share. With increasing number of diabetic patients and convenience offered by insulin pens, most patients prefer these pen, thereby making it a leading product in the insulin delivery devices market.
Other products include the insulin pump, which is a device attached to the patient and delivers regular doses of insulin. On the other hand, syringes are needles/injections that administer insulin. Other products such as jet sprays, etc., also occupy a considerable revenue share in the market.
Insulin Delivery Devices Distribution Channel Insights
Insulin delivery devices can be obtained from a number of different distribution channels such as hospital pharmacies, retail pharmacies, online sales, and diabetic clinics & centers. With advancements in e-Commerce and new technologies, patients are using online services of buying insulin delivery devices; they don’t need to visit any pharmacy or clinic, and this improves the convenience factor of online sales of insulin delivery devices and products. Retail pharmacies and hospital pharmacies also comprise a significant portion of the market, based on distribution.
Regional Outlook of Insulin Delivery Devices Market
When it comes to common diseases such as diabetes, patients can be found in all corners of the world. This makes the insulin delivery devices market very diverse, expanding to all regions such as North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. However, due to immense rise in the number of diabetic patients and obesity, North America is seen as a dominant region in the market based on revenue, accounting for over one-third of the insulin delivery devices market share. On the other hand, the Asian region will see an intense growth in the market due to rapid increase in population. Europe holds a steady and considerable position in this market space.
For more valuable information on regional market dynamics for insulin deliver devices, request a report sample
Insulin Delivery Devices Market: Key Players
The Insulin delivery devices market is fragmented in nature, where top players account for over half of the market share. Products are sold by a number of multinational and regional companies, out of which, major players are Sanofi SA, Medtronic PLC, Novo Novardisk A/S and Eli Lilly & Company. Other players are B. Braun Melsungen AG, Becton, Dickinson and Company, Biocon Ltd., Owen Mumford Ltd., Cellnova Group SA, Yepsomed Holding AG, F. Hoffmann-La Roche Ltd., Valeritas Inc., Tandem Diabetes Care, Inc., Insulet Corporation, SOOIL Development Co., Ltd, and Mannkind Corporation.
For a dashboard view of key players operating in the insulin deliver devices market, request a expert analyst
The Analyst’s Viewpoint
“Investing in research & development for creating devices with advanced futuristic technologies, such as smart insulin pens, will gain dominance in the market, thereby increasing overall revenue.”
COVID-19 Impact on Insulin Delivery Devices Market
The COVID-19 outbreak has had a significant negative impact, globally, from a business standpoint. However, this has not been the case for the insulin delivery devices market. Major reason being, increase in number of diabetic patients and rising obesity. Furthermore, due to the threat caused by the pandemic, people are buying more and more products for safety reasons, which is leading to a considerable growth in the market. Key players in the insulin delivery devices market have used this to benefit their revenue streams because of increased demand.
Insulin Delivery Devices Market: About the Report
Fact.MR has published an exclusive forecast report on the insulin delivery devices market for 2020 and 2030. The foremost objective of this report on the insulin delivery devices market is to pitch spearhead insights on the market scenario, demand generators, and technological advancements in the market. Also, the study addresses key dynamics that are expected to diversify the sales and future prominence of the insulin delivery devices market.
The report on the insulin delivery devices market begins with an executive overview, in which, product definition has been provided. The report further proceeds with the taxonomy of the insulin delivery devices market, elaborating on key segments. The report also outlines visionary insights on the dynamics of the insulin delivery devices market, including the drivers, restraints, opportunities, trends, and pricing analysis, along with the key buying factors for insulin delivery devices. Supply chain analysis and pricing analysis of the insulin delivery devices market along with the difference between insulin delivery devices used as per application has also been included in the report, to help readers clearly understand the product framework map in the insulin delivery devices market space.
Insulin Delivery Devices Market - Scope of the Report
A recent study by Fact.MR on the insulin delivery devices market offers a 10-year forecast for 2020 and 2030. The study analyzes crucial trends that are currently determining the growth of the insulin delivery devices market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of insulin delivery devices. The study also provides dynamics that are responsible for influencing the future status of the insulin delivery devices market over the forecast period.
A detailed assessment of the insulin delivery devices value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the insulin delivery devices market along with their product portfolio enhances the reliability of this comprehensive research study.
Insulin Delivery Devices Market: Report Summary
The study offers a comprehensive analysis on diverse features, including demand, product developments, revenue generation, and sales in the insulin delivery devices market across the globe.
A comprehensive estimate on the insulin delivery devices market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of insulin delivery devices during the forecast period. Price point comparison by region with global average price is also considered in the study.
Insulin Delivery Devices Market: Segmentation
Fact.MR has studied the insulin delivery devices market with detailed segmentation on the basis of by type, distribution channel, and key regions.
|
Type |
Distribution Channel |
Region |
|
Insulin Pens |
Hospital Pharmacies |
North America |
|
Insulin Syringes |
Retail Pharmacies |
Latin America |
|
Insulin Pumps |
Online Sales |
Europe |
|
Others |
Diabetes Clinics/Centers |
Asia Pacific |
|
|
|
Middle East & Africa |
|
|
|
|
|
|
|
|
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Insulin Delivery Devices Market: Analysis on Market Size Evaluation
The insulin delivery devices market has been analyzed for each market segment in terms of volume (Units) and value (US$ Mn).
Market estimates at global and regional levels for insulin delivery devices are available in terms of “US$ Mn” for value and in “units” for volume. A Y-o-Y growth contrast on prominent insulin delivery devices market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global insulin delivery devices market.
Insulin Delivery Devices Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the insulin delivery devices market report, which have helped deliver projections on regional markets. These chapters include regional macros (political economic and business environment outlook), which are expected to have a momentous influence on the growth of insulin delivery devices market during the forecast period.
Country-specific valuation on demand for insulin delivery devices has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value and volume for emerging countries has also been included in the report.
Insulin Delivery Devices Market: In-Depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of insulin delivery devices, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of insulin delivery devices has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status and predicting the competition level in insulin delivery devices market. Prominent companies operating in the global insulin delivery devices market include Becton, Dickinson and Company, Sanofi S.A., Medtronic PLC, B. Braun Melsungen AG, Novo Novardisk A/S, Eli Lilly and Company, Biocon Ltd., Owen Mumford Ltd., Cellnova Group SA, Yepsomed Holding AG, F. Hoffmann-La Roche Ltd., Valeritas Inc., Tandem Diabetes Care, Inc., Insulet Corporation, SOOIL Development Co. Ltd, and Mannkind Corporation.
1. Executive Summary
1.1. Summary of Key Findings
1.2. Summary of Statistics
1.3. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Introduction
2.2. Market Definition
2.3. Market Taxonomy
3. Market Risks & Trends Assessment
3.1. COVID-19 Impact Benchmark with Previous Crisis
3.1.1. Change in Insulin Delivery Devices Demand and Consumption Growth
3.1.2. Before and After COVID-19 Crisis (Projected)
3.1.3. Before and after SARS Pandemic (Actual)
3.1.4. Before and After Sub-prime Crisis – 2008 (Actual)
3.1.5. Change in Demand post Recovery Period (After Each Crisis)
3.2. Impact on Market Value (US$ Mn)
3.2.1. Likely Loss of Value in 2020
3.2.2. Mid-term and Long Term Forecast
3.2.3. Quarter by Quarter Dip and Recovery Assessment
3.3. Anticipated Demand and Value Recovery Curve
3.3.1. Likelihood of U-Shape Recovery
3.3.2. Likelihood of L-Shape Recovery
3.4. Recovery Period Assessment by Key Countries
4. Market Background and Associated Industry Indicators
4.1. Global Pharmaceutical Industry Outlook
4.1.1. Key trends in the pharmaceutical market
4.1.2. Pharmaceutical market, by region
4.2. Global Healthcare Industry Outlook
4.3. Statistics on Diabetic Patients
4.4. Global Drug Delivery Devices Market Outlook
4.5. Forecast Factors - Relevance & Impact for Insulin Delivery Devices
4.5.1. Key Market Players Historic Growth
4.5.2. Pharmaceutical Industry Growth Outlook
4.5.3. Drug Delivery Device Industry Outlook
4.5.4. Others
4.6. Value Chain Analysis and Operating Margins
4.6.1. List of Raw Material Suppliers
4.6.2. List of Key Manufacturers
4.6.3. List of End-users
4.6.4. Profit Margins
4.6.5. Notes on Value Added at Each Node in the Value Chain
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints and Market Risks
4.7.3. Opportunity Analysis
5. Global Insulin Delivery Devices Market Volume (Units) Demand Analysis 2015-2019 and Forecast, 2020-2030
5.1. Historical Market Volume (Units) Analysis, 2015-2019
5.2. Current and Future Market Volume (Units) Projections, 2020-2030
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Insulin Delivery Devices Market - Pricing Analysis
6.1. Regional Pricing Analysis
6.2. Pricing Break-up
6.3. Global Average Pricing Analysis Benchmark
7. Global Insulin Delivery Devices Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2015 - 2019
8.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product Type, 2020-2030
8.3.1. Insulin Pens
8.3.2. Insulin Syringes
8.3.3. Insulin Pumps
8.3.4. Others
8.4. Market Attractiveness Analysis By Product Type
9. Global Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2015 - 2019
9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Distribution, 2020-2030
9.3.1. Hospital Pharmacy
9.3.2. Retail Pharmacy
9.3.3. Online Sales
9.3.4. Diabetes Clinics & Centres
9.4. Market Attractiveness Analysis By Distribution Channel
10. Global Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030, By Region
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2015 - 2019
10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2018 – 2026
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. Asia Pacific
10.3.6. Middle East & Africa
11. North America Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019
11.4. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
11.4.1. By Country
11.4.1.1. U.S.
11.4.1.2. Canada
11.4.2. By Product Type
11.4.3. By Distribution Channel
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Distribution Channel
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Latin America Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019
12.4. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Product Type
12.4.3. By Distribution Channel
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Distribution Channel
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Western Europe Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019
13.4. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. Italy
13.4.1.3. France
13.4.1.4. U.K.
13.4.1.5. Spain
13.4.1.6. Rest of Western Europe
13.4.2. By Product Type
13.4.3. By Distribution Channel
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Distribution Channel
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Eastern Europe Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019
14.4. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
14.4.1. By Country
14.4.1.1. Russia
14.4.1.2. Poland
14.4.1.3. Rest of Eastern Europe
14.4.2. By Product Type
14.4.3. By Distribution Channel
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Distribution Channel
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Asia Pacific Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019
15.4. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
15.4.1. By Country
15.4.1.1. China
15.4.1.2. South Korea
15.4.1.3. India
15.4.1.4. Japan
15.4.1.5. Vietnam
15.4.1.6. Malaysia
15.4.1.7. Indonesia
15.4.1.8. Rest of APAC
15.4.2. By Product Type
15.4.3. By Distribution Channel
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Distribution Channel
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 - 2019
16.4. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2020-2030
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. Israel
16.4.1.3. South Africa
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Country
16.4.3. By Product Type
16.4.4. By Distribution Channel
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Distribution Channel
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Key Countries Insulin Delivery Devices Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Insulin Delivery Devices Market Analysis
17.2.1. Pricing Analysis
17.2.2. Market Value Proportion Analysis by Market Taxonomy
17.2.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.2.3.1. By Product Type
17.2.3.2. By Distribution Channel
17.3. Canada Insulin Delivery Devices Market Analysis
17.3.1. Pricing Analysis
17.3.2. Market Value Proportion Analysis by Market Taxonomy
17.3.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.3.3.1. By Product Type
17.3.3.2. By Distribution Channel
17.4. Germany Insulin Delivery Devices Market Analysis
17.4.1. Pricing Analysis
17.4.2. Market Value Proportion Analysis by Market Taxonomy
17.4.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.4.3.1. By Product Type
17.4.3.2. By Distribution Channel
17.5. France Insulin Delivery Devices Market Analysis
17.5.1. Pricing Analysis
17.5.2. Market Value Proportion Analysis by Market Taxonomy
17.5.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.5.3.1. By Product Type
17.5.3.2. By Distribution Channel
17.6. UK Insulin Delivery Devices Market Analysis
17.6.1. Pricing Analysis
17.6.2. Market Value Proportion Analysis by Market Taxonomy
17.6.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.6.3.1. By Product Type
17.6.3.2. By Distribution Channel
17.7. BENELUX Insulin Delivery Devices Market Analysis
17.7.1. Pricing Analysis
17.7.2. Market Value Proportion Analysis by Market Taxonomy
17.7.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.7.3.1. By Product Type
17.7.3.2. By Distribution Channel
17.8. Russia Insulin Delivery Devices Market Analysis
17.8.1. Pricing Analysis
17.8.2. Market Value Proportion Analysis by Market Taxonomy
17.8.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.8.3.1. By Product Type
17.8.3.2. By Distribution Channel
17.9. India Insulin Delivery Devices Market Analysis
17.9.1. Pricing Analysis
17.9.2. Market Value Proportion Analysis by Market Taxonomy
17.9.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.9.3.1. By Product Type
17.9.3.2. By Distribution Channel
17.10. Malaysia Insulin Delivery Devices Market Analysis
17.10.1. Pricing Analysis
17.10.2. Market Value Proportion Analysis by Market Taxonomy
17.10.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.10.3.1. By Product Type
17.10.3.2. By Distribution Channel
17.11. China Insulin Delivery Devices Market Analysis
17.11.1. Pricing Analysis
17.11.2. Market Value Proportion Analysis by Market Taxonomy
17.11.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.11.3.1. By Product Type
17.11.3.2. By Distribution Channel
17.12. Poland Insulin Delivery Devices Market Analysis
17.12.1. Pricing Analysis
17.12.2. Market Value Proportion Analysis by Market Taxonomy
17.12.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.12.3.1. By Product Type
17.12.3.2. By Distribution Channel
17.13. South Korea Insulin Delivery Devices Market Analysis
17.13.1. Pricing Analysis
17.13.2. Market Value Proportion Analysis by Market Taxonomy
17.13.3. Market Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
17.13.3.1. By Product Type
17.13.3.2. By Distribution Channel
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Insulin Delivery Devices)
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep pe
19.3.1. Becton, Dickinson and Company
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.2. Sanofi S.A.
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Product/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.3. Medtronic plc
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Product/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.4. B. Braun Melsungen AG
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Product/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.5. Novo Novardisk A/S
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Product/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.6. Eli Lilly and Company
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Profitability by Market Segments (Product/Region)
19.3.6.4. Sales Footprint
19.3.6.5. Strategy Overview
19.3.7. Biocon Ltd.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Profitability by Market Segments (Product/Region)
19.3.7.4. Sales Footprint
19.3.7.5. Strategy Overview
19.3.8. Owen Mumford Ltd.
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Profitability by Market Segments (Product/Region)
19.3.8.4. Sales Footprint
19.3.8.5. Strategy Overview
19.3.9. Cellnova Group SA
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Profitability by Market Segments (Product/Region)
19.3.9.4. Sales Footprint
19.3.9.5. Strategy Overview
19.3.10. Yepsomed Holding AG
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Profitability by Market Segments (Product/Region)
19.3.10.4. Sales Footprint
19.3.10.5. Strategy Overview
19.3.11. F. Hoffmann-La Roche Ltd.
19.3.11.1. Overview
19.3.11.2. Product Portfolio
19.3.11.3. Profitability by Market Segments (Product/Region)
19.3.11.4. Sales Footprint
19.3.11.5. Strategy Overview
19.3.12. Valeritas Inc.
19.3.12.1. Overview
19.3.12.2. Product Portfolio
19.3.12.3. Profitability by Market Segments (Product/Region)
19.3.12.4. Sales Footprint
19.3.12.5. Strategy Overview
19.3.13. Tandem Diabetes Care, Inc.
19.3.13.1. Overview
19.3.13.2. Product Portfolio
19.3.13.3. Profitability by Market Segments (Product/Region)
19.3.13.4. Sales Footprint
19.3.13.5. Strategy Overview
19.3.14. Insulet Corporation
19.3.14.1. Overview
19.3.14.2. Product Portfolio
19.3.14.3. Profitability by Market Segments (Product/Region)
19.3.14.4. Sales Footprint
19.3.14.5. Strategy Overview
19.3.15. SOOIL Development Co., Ltd
19.3.15.1. Overview
19.3.15.2. Product Portfolio
19.3.15.3. Profitability by Market Segments (Product/Region)
19.3.15.4. Sales Footprint
19.3.15.5. Strategy Overview
19.3.16. Mannkind Corporation
19.3.16.1. Overview
19.3.16.2. Product Portfolio
19.3.16.3. Profitability by Market Segments (Product/Region)
19.3.16.4. Sales Footprint
19.3.16.5. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Our Clients
Fact.MR in Media
Our analysts in Media
Insulin Delivery Devices Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030